Saturday 17 October 2026
Export SBC’s income statement to Excel — free account
SBC Medical Group Holdings Incorporated
SBC Industrials Consulting Services
SBC Medical Group Holdings Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $173.6 million, down 15.5% from fiscal 2024. In the quarter to June 2026, revenue grew 13.4%, EPS grew 400.0%, free cash flow grew 396.1% and total debt rose 420.7%, each against the same quarter a year earlier. Dividend growth for five consecutive years.
5.16
0.14
−2.64%
Follow SBC
| Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 3 |
P/E ratio |
— | 26.38 | 11.44 | 8.80 |
Altman Z-Score |
— | 8.06 | 7.73 | 4.74 |
P/S ratio |
— | 0.00 | 2.61 | 2.56 |
P/FCF ratio |
— | 20.08 | 31.26 | 14.91 |
Altman Z″-Score (non-manufacturers) |
— | 6.81 | 10.02 | 8.55 |
Beneish M-Score |
— | — | (1.97) | (1.96) |
P/Operating CF |
— | 36.44 | (73.51) | 8.54 |
P/B ratio |
— | 7.07 | 2.75 | 1.69 |
Price to Tangible BV |
— | 8.44 | 2.84 | 2.22 |
EV/Sales |
— | 0.00 | 2.04 | 1.86 |
EV/EBITDA |
— | 12.67 | 5.65 | 4.60 |
EV/Operating CF |
— | 18.30 | 20.33 | 13.08 |
EV/FCF |
— | 18.30 | 24.36 | 10.84 |
Quick Ratio |
0.86 | 1.59 | 2.71 | 3.34 |
Current Ratio |
1.28 | 1.79 | 3.01 | 3.78 |
Net Debt/EBITDA |
0.89 | (1.08) | (1.60) | (1.73) |
Debt/Assets |
0.00% | 5.09% | 2.48% | 11.29% |
Debt/Equity |
0.00 | 0.09 | 0.03 | 0.16 |
Asset Turnover |
— | 1.02 | 0.78 | 0.54 |
Operating CF/Net income |
(0.84) | 1.29 | 0.44 | 0.48 |
Capex/Depreciation |
— | (0.26) | (0.90) | 1.90 |
Interest Coverage |
(0.40) | 1,559.83 | 2,484.23 | 420.21 |
| 0.00% | 56.06% | 27.51% | 22.25% | |
| 0.00% | 20.79% | 17.76% | 15.77% | |
ROIC |
0.00% | 81.85% | 57.38% | 29.67% |
Return on Tangible Assets |
353.91% | 45.23% | 35.31% | 28.70% |
Average Days of Receivables |
— | 82.22 | 72.22 | 83.64 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 34.22% | 34.41% | 34.44% |
Intangible Assets out of Total Assets |
0.00 | 0.09 | 0.02 | 0.17 |
Share Based Compensation of Revenue |
— | 0.00% | 6.34% | 0.00% |
Graham Net Nets |
— | 0.05 | 0.21 | 0.26 |
Graham Number |
— | 3.75 | 4.70 | 5.31 |
Earnings Yield |
— | 3.79% | 8.74% | 11.37% |
Free Cash Flow Yield |
— | 4.98% | 3.20% | 6.71% |
Revenue per Share |
0.00 | 2.05 | 2.13 | 1.69 |
Operating CF per Share |
(0.17) | 0.54 | 0.21 | 0.24 |
Capex per Share |
0.00 | (0.03) | (0.04) | 0.05 |
Free Cash Flow per Share |
(0.17) | 0.50 | 0.18 | 0.29 |
Cash per Share |
0.18 | 1.09 | 1.30 | 1.59 |
Shareholders Equity per Share |
(1.25) | 1.53 | 2.02 | 2.56 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(1.25) | 1.53 | 2.02 | 2.56 |
Free Cash Flow |
(0.46) | 47.51 | 17.17 | 29.78 |
Working Capital |
0.16 | 73.45 | 123.26 | 170.10 |
Capital Expenditures |
— | (3.16) | (3.41) | 5.11 |
Net Current Asset Value |
(122.58) | 50.91 | 113.39 | 114.08 |
EV/EBIT |
— | 13.13 | 5.95 | 4.78 |
Capex to Sales |
— | 0.02 | 0.02 | (0.03) |
Price to Operating Income |
— | 14.40 | 7.64 | 6.58 |
| Other line items | ||||
Depreciation/Fixed assets |
— | 0.90 | 0.43 | 0.36 |
Cash ROIC |
16.11% | 18.27% | 5.26% | 6.33% |
Accounts Receivable Turnover |
— | 0.00 | 4.88 | 4.32 |
Accounts Payable Turnover |
— | 4.23 | 2.40 | 2.88 |
Inventory Turnover |
— | 0.00 | 21.53 | 21.61 |
Average Days of Payables |
0.00 | 172.20 | 107.46 | 138.99 |
Days of Inventory on Hand |
— | 20.06 | 11.05 | 22.00 |
Average Receivables |
— | — | 42.12 | 40.21 |
Average Payables |
— | 13.31 | 20.53 | 16.09 |
Average Inventory |
— | — | 2.29 | 2.14 |
Average Assets |
— | 189.37 | 262.44 | 323.27 |
Average Common Equity |
— | 70.23 | 169.42 | 229.16 |
Columns are period end dates